Pharma: Novartis shares dropped 9% following three setbacks in clinical trials for its drugs.
Novartis shares plummeted on Tuesday following disappointing results from the del-desiran drug trial, leaving investors unsettled. Stay tuned for updates on how this may impact the company's future! #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
